These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6769399)

  • 1. Gold binding to blood cells and serum proteins during chrysotherapy.
    van de Stadt RJ; Abbo-Tilstra B
    Ann Rheum Dis; 1980 Feb; 39(1):31-6. PubMed ID: 6769399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination.
    van Riel PL; Gribnau FW; van de Putte LB
    J Rheumatol; 1983 Aug; 10(4):574-8. PubMed ID: 6413685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of gold in blood during chrysotherapy.
    Francois PE; Goldberg IJ; Lawton K; Al-Ani DT; Redding JH
    Ann Clin Biochem; 1978 Nov; 15(6):324-5. PubMed ID: 104649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum gold. II. Levels in rheumatoid arthritis.
    Rubinstein HM; Dietz AA
    Ann Rheum Dis; 1973 Mar; 32(2):128-32. PubMed ID: 4266407
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitation of gold lymphocyte binding during chrysotherapy.
    Lorber A; Wilcox S; Leeb J; Simon T
    J Rheumatol; 1979; 6(3):270-6. PubMed ID: 114635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of gold among plasma fractions in rheumatoid patients undergoing chrysotherapy compared with its distribution in plasma incubated with aurothiomalate in vitro.
    Danpure CJ; Fyfe DA; Gumpel JM
    Ann Rheum Dis; 1979 Aug; 38(4):364-70. PubMed ID: 115389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.
    Finkelstein AE; Roisman FR; Batista V; de Nudelman FG; de Titto EH; Mizraji M; Walz DT
    J Rheumatol; 1980; 7(2):160-8. PubMed ID: 6768887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of cigarette smoking on blood gold distribution during chrysotherapy.
    James DW; Ludvigsen NW; Cleland LG; Milazzo SC
    J Rheumatol; 1982; 9(4):532-5. PubMed ID: 6813469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gold levels produced by treatment with auranofin and sodium aurothiomalate.
    Lewis D; Capell HA; McNeil CJ; Iqbal MS; Brown DH; Smith WE
    Ann Rheum Dis; 1983 Oct; 42(5):566-70. PubMed ID: 6414387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold in erythrocytes, whole blood, and plasma during long-term chrysotherapy.
    Pedersen SM; Graabaek PM
    Ann Rheum Dis; 1980 Dec; 39(6):576-9. PubMed ID: 7458435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum gold. I. Estimation by atomic absorption spectroscopy.
    Dietz AA; Rubinstein HM
    Ann Rheum Dis; 1973 Mar; 32(2):124-7. PubMed ID: 4632660
    [No Abstract]   [Full Text] [Related]  

  • 12. Gold distribution in whole blood during chrysotherapy.
    Smith PM; Smith EM; Gottlieb NL
    J Lab Clin Med; 1973 Dec; 82(6):930-7. PubMed ID: 4202278
    [No Abstract]   [Full Text] [Related]  

  • 13. [Distribution of gold from aurothiomalate and gold trielthylphosphine in whole blood, lymphocytes and lymphocyte chromatin of patients with chronic polyarthritis].
    Teherani DK; Altmann H; Tausch G; Eberl R
    Wien Klin Wochenschr Suppl; 1984; 156():53-5. PubMed ID: 6442060
    [No Abstract]   [Full Text] [Related]  

  • 14. Chrysotherapy in rheumatoid arthritis with particular emphasis on the effect of chrysotherapy on radiographical changes and on the optimal time of initiation of therapy.
    Luukkainen R
    Scand J Rheumatol Suppl; 1980; 34():1-56. PubMed ID: 6791272
    [No Abstract]   [Full Text] [Related]  

  • 15. [The detection of gold atoms in lymphocyte and erythrocyte chromatin following therapy with 2 different gold compounds in patients with chronic polyarthritis].
    Bröll H; Tausch G; Teherani DK
    Wien Klin Wochenschr Suppl; 1984; 156():16. PubMed ID: 6442049
    [No Abstract]   [Full Text] [Related]  

  • 16. [Protein binding of gold in serum of patients treated with different gold preparations].
    Herrlinger JD; Weikert W
    Z Rheumatol; 1982; 41(5):230-4. PubMed ID: 6818790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and distribution of gold compounds.
    Gottlieb NL
    J Rheumatol Suppl; 1979; 5():2-6. PubMed ID: 114646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of gold in serum erythrocytes and white blood cells after in vitro incubation and during chrysotherapy with different gold compounds.
    Herrlinger JD; Alsen C; Beress R; Hecker U; Weikert W
    J Rheumatol Suppl; 1982; 8():81-9. PubMed ID: 6813496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. II. Unbound versus total serum gold concentration: pharmacological actions on cellular function.
    Lorber A; Kunishima DH; Harralson AF; Simon TM
    J Rheumatol; 1983 Aug; 10(4):568-73. PubMed ID: 6413684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary results of oral gold treatment with auranofin following lack of success of intramuscular gold therapy].
    Rainer F; Ulreich A
    Wien Klin Wochenschr Suppl; 1984; 156():49-51. PubMed ID: 6442058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.